For patients undergoing percutaneous coronary intervention (PCI), tailoring antiplatelet therapy based on the results of platelet function testing makes no difference in the risk of recurrent ischemic ...
Platelet function testing technology will complement Roche's full line of coagulation analyzers targeted for introduction in US and Canada in 2014 The acquisition supports plans Roche announced in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results